Article Details

Myriad Genetics, Inc. (NASDAQ:MYGN) Is Worth Evaluating At $28.93

Retrieved on: 2021-02-06 12:30:02

Tags for this article:

Click the tags to see associated articles and topics

Myriad Genetics, Inc. (NASDAQ:MYGN) Is Worth Evaluating At $28.93. View article details on hiswai:

Excerpt

The next largest institutional holding, with 8Million shares, is of Vanguard Group, Inc. (The)'s that is approximately 10.63% of outstanding shares.

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo